CTD-ILD: Rituximab ' a Reasonable Alternative to Cyclophosphamide ' CTD-ILD: Rituximab ' a Reasonable Alternative to Cyclophosphamide '

A clinical trial found that rituximab and cyclophosphamide had similar outcomes for interstitial lung disease associated with connective tissue disorders.MDedge News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Rheumatology News Source Type: news